Modulation of PKC signaling and induction of apoptosis through suppression of reactive oxygen species and tumor necrosis factor receptor 1 (TNFR1): key role of quercetin in cancer prevention

Tumor Biology

Volumn 36, Issue 11, 2015, Pages 8913-8924

  Maurya, Akhilendra Kumar ^a   Vinayak, Manjula ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Apoptosis; PKC; Quercetin; ROS; TNFR1 and Dalton s lymphoma

Indexed keywords

CASPASE 3; CASPASE 9; DEATH RECEPTOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN KINASE C; PROTEIN KINASE C ALPHA; PROTEIN KINASE C DELTA; QUERCETIN; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR RECEPTOR 1; ISOENZYME;

ADULT; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER PREVENTION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; T CELL LYMPHOMA; UPREGULATION; ANIMAL; BIOSYNTHESIS; CELL PROLIFERATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LYMPHOMA; METABOLISM; PATHOLOGY;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; CELL SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ISOENZYMES; LYMPHOMA; MICE; OXIDATIVE STRESS; PROTEIN KINASE C-ALPHA; QUERCETIN; REACTIVE OXYGEN SPECIES; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SIGNAL TRANSDUCTION;

EID: 84949098454     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-3634-5     Document Type: Article

References (68)

1. Nogueira V, Hay N. Molecular pathways: reactive oxygen species homeostasis in cancer cells and implications for cancer therapy. Clin Cancer Res. 2013;19:4309–14.
2. Sosa V, Moliné T, Somoza R, Paciucci R, Kondoh H, LLeonart ME. Oxidative stress and cancer: an overview. Ageing Res Rev. 2013;12:376–90.
3. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact. 2006;160:1–40.
4. Ivanova D, Bakalova RLD, et al. The impact of reactive oxygen species. Clin Adv Med Exp. 2013;22:899–908.
5. Weinberg F, Chandel NS. Reactive oxygen species-dependent signaling regulates cancer. Cell Mol Life Sci. 2009;66:3663–73.
6. Naka K, Muraguchi T, Hoshii T, Hirao A. Regulation of reactive oxygen species and genomic stability in hematopoietic stem cells. Antioxid Redox Signal. 2008;10:1883–94.
7. Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach. Nat Rev Drug Discov. 2009;8:579–91.
8. Coleman WB, Tsongalis GJ. Molecular mechanisms of human carcinogenesis. Cancer: cell structures, carcinogens and genomic instability. EXS. 2006;96:321–49.
9. Wu WS. The signaling mechanism of ROS in tumor progression. Cancer Metastasis Rev. 2006;25:695–705.
10. Gopalakrishna R, Gundimeda U. Antioxidant regulation of protein kinase C in cancer prevention. J Nutr. 2002;132:3819–23.
11. Trachootham D, Lu W, Ogasawara MA, Nilsa RDV, Huang P. Redox regulation of cell survival. Antioxid Redox Signal. 2008;10:1343–74.
12. Zhou F, Shen Q, Claret FX. Novel roles of reactive oxygen species in the pathogenesis of acute myeloid leukemia. J Leukoc Biol. 2013;94:423–9.
13. Saeidnia S, Abdollahi M. Antioxidants: friends or foe in prevention or treatment of cancer: the debate of the century. Toxicol Appl Pharmacol. 2013;271:49–63.
14. Samoylenko A, Hossain J, Mennerich D, Kellokumpu S, Hiltunen JK, Kietzmann T. Nutritional countermeasures targeting reactive oxygen species in cancer: from mechanisms to biomarkers and clinical evidence. Antioxid Redox Signal. 2013;19:2157–96.
15. Glasauer A, Chandel NS. Targeting antioxidants for cancer therapy. Biochem Pharmacol. 2014;92:90–101.
16. Hu CT, Wu JR, Cheng CC, Wang S, Wang HT, Lee MC, et al. Reactive oxygen species-mediated PKC and integrin signaling promotes tumor progression of human hepatoma HepG2. Clin Exp Metastasis. 2011;28:851–63.
17. Aspects D, Giorgi C, Agnoletto C, Baldini C, Bononi A, Bonora M, et al. Redox control of protein kinase C: cell-and disease-specific aspects. Antioxid Redox Signal. 2010;13:1051–85.
18. Paulsen CE, Carroll KS. Orchestrating redox signaling networks through regulatory cysteine switches. ACS Chem Biol. 2010;5:47–62.
19. Frey RS, Gao X, Javaid K, Siddiqui SS, Rahman A, Malik AB. Phosphatidylinositol 3-kinase gamma signaling through protein kinase Czeta induces NADPH oxidase-mediated oxidant generation and NF-kappaB activation in endothelial cells. J Biol Chem. 2006;281:16128–38.
20. Talior I, Tennenbaum T, Kuroki T, Eldar-Finkelman H. PKC-delta-dependent activation of oxidative stress in adipocytes of obese and insulin-resistant mice: role for NADPH oxidase. Am J Physiol Endocrinol Metab. 2005;288:405–11.
21. Caino MC, Meshki J, Kazanietz MG. Hallmarks for senescence in carcinogenesis: novel signaling players. Apoptosis. 2009;14:392–408.
22. Mishra S, Vinayak M. Anti-carcinogenic action of ellagic acid mediated via modulation of oxidative stress regulated genes in Dalton lymphoma bearing mice. Leuk Lymphoma. 2011;52:2155–61.
23. Lee SK, Shehzad A, Jung JC, Sonn JK, Lee JT, Park JW, et al. Protein kinase Cα protects against multidrug resistance in human colon cancer cells. Mol Cells. 2012;34:61–9.
24. Konopatskaya O, Poole AW. Protein kinase Calpha: disease regulator and therapeutic target. Trends Pharmacol Sci. 2010;31:8–14.
25. Wu TT, Hsieh YH, Hsieh YS, Liu JY. Reduction of PKC alpha decreases cell proliferation, migration, and invasion of human malignant hepatocellular carcinoma. J Cell Biochem. 2008;103:9–20.
26. Zhao M, Xia L, Chen GQ. Protein kinase cδ in apoptosis: a brief overview. Arch Immunol Ther Exp. 2012;60:361–72.
27. Reyland ME. Protein kinase C δ and apoptosis. Biochem Soc Trans. 2007;35:1001–4.
28. Ghayur BT, Hugunin M, Talanian RV, Ratnofsky S, Quinlan C, Emoto Y, et al. Proteolytic activation of protein kinase C δ by an ICE/CED 3-like protease induces characteristics of apoptosis. J Exp Med. 1996;184:2399–404.
29. Kanthasamy AG, Kitazawa M, Yang Y, Anantharam V, Kanthasamy A. Environmental neurotoxin dieldrin induces apoptosis via caspase-3-dependent proteolytic activation of protein kinase C delta (PKCdelta): implications for neurodegeneration in Parkinson’ s disease. Mol Brain. 2008;12:1–15. doi:10.1186/1756-6606-1-12.
30. Oh J, Chun K, Joo S, Oh Y, Lee S. Caspase-3-dependent protein kinase C delta activity is required for the progression of Ginsenoside-Rh2-induced apoptosis in SK-HEP-1 cells. Cancer Lett. 2005;230:228–38.
31. Thorburn A. Death receptor-induced cell killing. Cell Signal. 2004;16:139–44.
32. Pobezinskaya YL, Liu Z. The role of TRADD in death receptor signaling. Cell Cycle. 2012;11:871–6.
33. Baud V, Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 2001;11:372–7.
34. Tracey D, Klareskog L, Sasso EH, Salfeld JG, Tak PP. Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol Ther. 2008;117:244–79.
35. Wajant H, Scheurich P. TNFR1-induced activation of the classical NF-κB pathway. FEBS J. 2011;278:862–76.
36. Maurya AK and Vinayak M. Quercetin regresses Dalton’s lymphoma growth via suppression of PI3K/AKT signaling leading to up regulation of p53 and decrease in energy metabolism. Nutr Cancer. 2014;67:354–63.
37. Hayashi A. Effects of daily oral administration of quercetin chalcone and modified citrus pectin on implanted colon-25 tumor growth in Balb-c mice. Altern Med Rev. 2006;5:546–52.
38. Goldie H, Dingman FM. Growth characteristics of free tumor cells transferred serially in the peritoneal fluid of the mouse. Cancer Res. 1951;11:73–80.
39. Aita K, Irie H, Tanuma Y, Toida S, Okuma Y, Mori S, et al. Apoptosis in murine lymphoid organs following intraperitoneal administration of dimethyl sulfoxide (DMSO). Exp Mol Pathol. 2005;79:265–71.
40. Chen N, Ma WY, Huang C, Dong Z. Translocation of protein kinase C and protein kinase C to membrane is required for ultraviolet B-induced activation of mitogen-activated protein kinases and apoptosis. J Biol Chem. 1999;274:15389–94.
41. Qian W, Nishikawa M, Haque AM, Hirose M, Mashimo M, Sato E, et al. Mitochondrial density determines the cellular sensitivity to cisplatin-induced cell death. Am J Physiol Cell Physiol. 2005;289:C1466–75.
42. Ribble D, Goldstein NB, Norris DA, Shellman YG. A simple technique for quantifying apoptosis in 96-well plates. BMC Biotechnol. 2005;7:1–7.
43. Das L, Vinayak M. Long term effect of curcumin in regulation of glycolytic pathway and angiogenesis via modulation of stress activated genes in prevention of cancer. PLoS ONE. 2014;9:1–12.
44. Mishra S, Vinayak M. Ellagic acid induces novel and atypical PKC isoforms and promotes caspase-3 dependent apoptosis by blocking energy metabolism. Nutr Cancer. 2014;66:675–81.
45. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007;35:495–516.
46. Gutcher I, Webb PR, Anderson NG. The isoform-specific regulation of apoptosis by protein kinase C. Cell Mol Life Sci. 2003;60:1061–70.
47. Mauro A. PKCalpha-mediated ERK, JNK and p38 activation regulates the myogenic program in human rhabdomyosarcoma cells. J Cell Sci. 2002;115:3587–99.
48. Martiny-Baron G, Fabbro D. Classical PKC isoforms in cancer. Pharmacol Res. 2007;55:477–86.
49. Lahn M, Sundell K, Gleave M, Ladan F, Su C, Li S, et al. Protein kinase C-α in prostate cancer. BJU Int. 2004;93:1076–81.
50. Zhang XM, Chen J, Xia YG, Xu Q. Apoptosis of murine melanoma B16-BL6 cells induced by quercetin targeting mitochondria, inhibiting expression of PKC-alpha and translocating PKC-delta. Cancer Chemother Pharmacol. 2005;55:251–62.
51. Gamet-Payrastre L, Manenti S, Gratacap M-P, Tulliez J, Chap H, Payrastre B. Flavonoids and the inhibition of PKC and PI 3-kinase. Gen Pharmacol Vasc Syst. 1999;32:279–86.
52. Granado-serrano AB, Martín MA, Bravo L, Goya L. Time-course regulation of quercetin on cell survival / proliferation pathways in human hepatoma cells. Mol Nutr Food Res. 2008;52:457–64.
53. Wu CH, Wu CF, Huang HW, Jao YC, Yen GC. Naturally occurring flavonoids attenuate high glucose-induced expression of proinflammatory cytokines in human monocytic THP-1 cells. Mol Nutr Food Res. 2009;53:984–95.
54. Ruvolo PP, Deng X, Carr BK, May WS, Biol WSJ, Reh H. A functional role for mitochondrial protein kinase Cα in Bcl2 phosphorylation and suppression of apoptosis. J Biol Chem. 1998;273:25436–42.
55. Popla YG, Murray NR, Velasco MA, Gatalica Z, Fields AP. Elevated protein kinase CβII is an early promotive event in colon carcinogenesis. Cancer Res. 2001;2:1375–81.
56. Kawakami Y, Nishimoto H, Kitaura J, Maeda-Yamamoto M, Kato RM, Littman DR, et al. Protein kinase C betaII regulates Akt phosphorylation on Ser-473 in a cell type- and stimulus-specific fashion. J Biol Chem. 2004;279:47720–5.
57. Numazawa S, Ishikawa M, Yoshida A, Tanaka S, Yoshida T. Atypical protein kinase C mediates activation of NF-E2-related factor 2 in response to oxidative stress. Am J Physiol Cell Physiol. 2003;285:334–42.
58. Kim JH, Kim JH, Ohba M, Suh PG, Ryu SH. Novel functions of the phospholipase D2-Phox homology domain in protein kinase Czeta activation. Mol Cell Biol. 2005;25:3194–208.
59. Chen G, Goeddel DV. TNF-R1 signaling: a beautiful pathway. Science. 2002;296:1634–5.
60. Micheau O, Boveresses C, Epalinges C. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell. 2003;114:181–90.
61. Liu Z, Hsu H, Goeddel DV, Karin M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell. 1996;87:565–76.
62. D’Alessio A, Kluger MS, Li JH, Al-Lamki R, Bradley JR, Pober JS. Targeting of tumor necrosis factor receptor 1 to low density plasma membrane domains in human endothelial cells. J Biol Chem. 2010;285:23868–79.
63. Rivas MA, Carnevale RP, Proietti CJ, Rosemblit C, et al. TNF α acting on TNFR1 promotes breast cancer growth via p42/p44 MAPK, JNK, Akt and NF-kB-dependant pathways. Exp Cell Res. 2008;314:509–29.
64. Guicciardi ME, Gores GJ. Life and death by death receptors. FASEB J. 2009;23:1625–37.
65. Brachert WS, Tchikov V, Neumeyer J, Jakob M, Morbach SW, Feindt JF, et al. Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles. Immunity. 2004;21:415–28.
66. Pan HC, Jiang Q, Yu Y, Mei JP, Cui YK, Zhao WJ. Quercetin promotes cell apoptosis and inhibits the expression of MMP-9 and fibronectin via the AKT and ERK signalling pathways in human glioma cells. Neurochem Int. 2015;80:60–71.
67. Basu A, Woolard MD, Johnson CL. Involvement of protein kinase C-delta in DNA damage-induced apoptosis. Cell Death Differ. 2001;8:899–908.
68. Hazeki K, Inoue K, Nigorikawa K, Hazeki O. Negative regulation of class IA phosphoinositide 3-kinase by protein kinase Cdelta limits Fcgamma receptor-mediated phagocytosis in macrophages. J Biochem. 2009;145:87–94.